Cellebrite DI Ltd. CLBT
NASDAQ · United States · Technology Services
$11.26+0.33 (+3.02%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Cellebrite (Nasdaq: CLBT), a global leader in Digital Investigative and Intelligence solutions for the public and private sectors, today announced the next evolution of the Digital Justice Awards, known as the JUSTYS. The 2027 program introduces more rigorous judging criteria, an elevated panel of judges and new crime-specific categories for its Case of the Year awards. The JUSTYS will be presented on Tuesday, April 13, 2027, during Cellebrite's annual C2C User Summit which attracts the best and
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Cellebrite DI (CLBT) sits in focus after recent share performance left the stock down over the past year, despite revenue of US$514.289m and net income of US$58.246m from its digital investigations platform. Cellebrite DI’s share price has slipped over recent months, with the stock down 35.2% year to date and 9.26% over the past quarter, even though the 30 day share price return of 4.62% shows a short burst of positive momentum against a weaker near term trend. Scan beyond Cellebrite DI and...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.